32 phenotypes from 4 alleles in 3 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Tle3em1(IMPC)Mbp/Tle3em1(IMPC)Mbp C57BL/6N-Tle3em1(IMPC)Mbp/MbpMmucd	abnormal brain morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal testis morphology	J:211773
	abnormal vitreous body morphology	J:211773
	cataract	J:211773
	decreased brain size	J:211773
	persistence of hyaloid vascular system	J:211773
	small spleen	J:211773
	small testis	J:211773
Tle3Gt(XP0165)Wtsi/Tle3Gt(XP0165)Wtsi involves: 129P2/OlaHsd	abnormal adipose tissue development	J:172245
	abnormal cell differentiation	J:172245
	embryonic lethality, complete penetrance	J:172245
Tle3tm1.1Pton/Tle3tm1.1Pton Tg(Adipoq-cre)1Evdr/0 involves: 129P2/OlaHsd * C57BL/6J * FVB/NJ	abnormal brown adipose tissue morphology	J:198134
	abnormal brown fat cell morphology	J:198134
	abnormal inguinal fat pad morphology	J:198134
	normal behavior/neurological phenotype	J:198134
	decreased susceptibility to induced hypothermia	J:198134
	increased core body temperature	J:198134
	increased energy expenditure	J:198134
Tle3tm1Jcc/Tle3tm1Jcc involves: 129P2/OlaHsd	abnormal pancreas development	J:183486
	abnormal pancreatic alpha cell differentiation	J:183486
	abnormal pancreatic alpha cell morphology	J:183486
	abnormal pancreatic beta cell differentiation	J:183486
	abnormal pancreatic beta cell morphology	J:183486
	abnormal pancreatic delta cell differentiation	J:183486
	abnormal pancreatic epsilon cell differentiation	J:183486
	abnormal pancreatic epsilon cell morphology	J:183486
	abnormal placenta morphology	J:183486
	abnormal PP cell differentiation	J:183486
	decreased embryo size	J:183486
	lethality throughout fetal growth and development, incomplete penetrance	J:183486
	small pancreas	J:183486